NCT02996357 is a clinical trial in Irritant Contact Dermatitis, sponsored by University Ghent.

Who is sponsoring NCT02996357?

NCT02996357 is sponsored by University Ghent.

What condition does NCT02996357 study?

NCT02996357 studies Irritant Contact Dermatitis, Diaper Rash, Incontinence-associated Dermatitis.

Is NCT02996357 still recruiting?

NCT02996357 is currently completed. Last updated 19 July 2017.

Last reviewed 2017-07-19 · How we verify

NCT02996357

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence

Completed Last updated 19 July 2017

What this trial tests

trial in Irritant Contact Dermatitis in 206 participants. Completed in 31 May 2017.

Timeline

4 October 2016

Primary endpoint
31 May 2017

31 May 2017

Quick facts

Lead sponsor	University Ghent
Status	Completed
Study type	OBSERVATIONAL
Enrollment	206
Start date	4 October 2016
Primary completion	31 May 2017
Estimated completion	31 May 2017
Sites	19 locations across Belgium

Conditions studied

Irritant Contact Dermatitis — all drugs for Irritant Contact Dermatitis →
Diaper Rash — all drugs for Diaper Rash →
Incontinence-associated Dermatitis — all drugs for Incontinence-associated Dermatitis →

Sponsor

University Ghent

Who can join

18 and older, any sex, with Irritant Contact Dermatitis or Diaper Rash. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to identify patient characteristics associated with the development of Incontinence-Associated Dermatitis (IAD) category 2 (skin erosion due to incontinence). 380 ICU patients suffering of fecal incontinence will be included in the study. Data on 19 possible risk factors will be collected at one point in time by the research team. Different sources and methods will be used to collect patient data: skin assessment, patient record, direct patient observation, routine blood samples.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Ghent trials

Trials by the same sponsor.

NCT07398053 — General Practitioner & Pharmacist Support for Discontinuing Long-term Antidepressants in Clinically Stable Patients · NA · not yet recruiting
NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline · NA · recruiting
NCT07091071 — Evaluation of the CochSyn Device in Clinical Practice · NA · completed
NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
NCT07176156 — Evaluation of the Quality of Chat Conversations With the Suicide Helpline Zelfmoordlijn 1813 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02996357 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Ghent
Last refreshed: 19 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02996357.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing